Antimicrobial and antibiofilm efficacy of triclosan and DispersinB® combination

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 1, 2009, Pages 88-93

  Darouiche, Rabih O ^a   Mansouri, Mohammad D ^a   Gawande, Purushottam V ^b   Madhyastha, Srinivasa ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Kane Biotech Inc   (Canada)

Author keywords

Bacteria; Catheter; Infection

Indexed keywords

ANTIINFECTIVE AGENT; CHLORHEXIDINE; DISPERSIN B; SULFADIAZINE SILVER; TRICLOSAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BIOFILM; CATHETER INFECTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ESCHERICHIA COLI; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MONOTHERAPY; NONHUMAN; RABBIT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PROTEINS; BIOFILMS; CATTLE; DRUG SYNERGISM; EQUIPMENT AND SUPPLIES; ESCHERICHIA COLI; GLYCOSIDE HYDROLASES; RABBITS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TRICLOSAN;

EID: 67249155699     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp158     Document Type: Article

References (24)

1. Haley RW. Estimating the extra charges and prolongation of hospitalization due to nosocomial infections: A comparison of methods. J Infect Dis 1980; 141: 248-57.
2. O'Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. Morb Mortal Wkly Rep Recomm Rep 2002; 51: 1-29.
3. Maki DG, Tambyan PA. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 2001; 7: 342-7.
4. Jones GL, Muller CT, O'Reilly M et al. Effect of triclosan on the development of bacterial biofilms by urinary tract pathogens on urinary catheters. J Antimicrob Chemother 2006; 57: 266-72.
5. Slater-Radosti C, Aller GV, Greenwood R et al. Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus. J Antimicrob Chemother 2001; 48: 1-6.
6. Itoh Y, Wang X, Hinnebusch BJ et al. Depolymerization of β-1,6- N-acetyel-D-glucosamine disrupts the integrity of diverse bacterial biofilms. J Bacteriol 2005; 187: 382-7.
7. Kaplan JB, Ragunath C, Velliyagounder K et al. Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2004; 48: 2633-6.
8. Gilbert P, McBain AJ. Literature-based evaluation of the potential risks associated with impregnation of medical devices and implanted with triclosan. Surg Infect 2002; 3 suppl 1: S55-63.
9. Donelli G, Francolini I, Romoli D et al. Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother 2007; 51: 2733-40.
10. Hernandez-Richter T, Schardey HM, Lohlein F et al. Binding kinetics of triclosan (Irgasan®) to alloplastic vascular grafts: An in vitro study. Ann Vasc Surg 2000; 14: 370-5.
11. Kaplan JB, Ragunath C, Ramasubbu N et al. Detachment of Actinobacillus actinomycetemcomitans biofilm cells by an endogenous β-hexosaminidase activity. J Bacteriol 2003; 185: 4693-8.
12. Dubendorff JW, Studier FW. Creation of a T7 autogene. Cloning and expression of the gene for bacteriophage T7 RNA polymerase under control of its cognate promoter. J Mol Biol 1991; 219: 61-8.
13. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
14. Jackson DW, Suzuki K, Oakford L et al. Biofilm formation and dispersal under the influence of the global regulator CsrA of Escherichia coli. J Bacteriol 2002; 184: 290-301.
15. Cormio L, Forgia PL, Forgia DL et al. Bacterial adhesion to urethral catheters: Role of coating materials and immersion in antibiotic solution. Eur Urol 2001; 40: 354-9.
16. Kim CY, Kumar A, Sampath L et al. Evaluation of an antimicrobial-impregnated continuous ambulatory peritoneal dialysis catheter for infection control in rats. Am J Kidney Dis 2002; 39: 165-73.
17. Sherertz RJ, Forman DM, Solomon DD. Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice. Antimicrob Agents Chemother 1989; 33: 1174-8.
18. Darouiche RO, Mansouri MD, Meade R. In vitro and in vivo activity of antimicrobial-coated prosthetic heart valve sewing cuffs. J Heart Valve Dis 2002; 11: 99-104.
19. Presterl E, Grisold AJ, Reichmann S et al. Viridans streptococci in endocarditis and neutropenic sepsis: Biofilm formation and effects of antibiotics. J Antimicrob Chemother 2005; 55: 45-50.
20. Izano EA, Wang H, Ragunath C et al. Detachment and killing of Aggregatibacter actinomycetemcomitans biofilms by dispersin B and SDS. J Dent Res 2007; 86: 618-22.
21. Izano EA, Sadovskaya I, Vinogradov E et al. Poly-N acetylglucosamine mediates biofilm formation and antibiotic resistance in Actinobacillus pleuropneumoniae. Microb Pathog 2007; 43: 1-9.
22. Rosenthal VD, Maki DG, Salomao R et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 2006; 145: 582-91.
23. Tunney MM, Gorman SP, Patrick S. Infection associated with medical devices. Rev Med Microbiol 1996; 7: 195-205.
24. Sampath LA, Saborio DV, Yaron I et al. Safety and efficacy of an improved antiseptic catheter impregnated intraluminally with chlorhexidine. J Infus Nurs 2001; 24: 395-403.